跳至主要内容
临床试验/NCT06609044
NCT06609044
已完成
不适用

Social and Psychological Long-term Impact of NMDA Receptor Encephalitis

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 20 人2024年12月16日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Autoimmune Encephalitis
发起方
Hospices Civils de Lyon
入组人数
20
试验地点
1
主要终点
Psychosocial questionnaires of patients with anti-NMDAR encephalitis after the acute phase of the disease.
状态
已完成
最后更新
4个月前

概览

简要总结

NMDA receptor antibody encephalitis is a rare autoimmune neurological disease of the central nervous system with an estimated incidence of 1.5 people per million per year. Patients with anti-NMDAR encephalitis experience an acute phase of the disease characterized by psychosis, memory loss, seizures, autonomic nervous system instability, or coma. Since the discovery of this disease 14 years ago by Prof. Dalmau, the clinical presentation of the acute phase has been well characterized, while the psychosocial impact of the disease remains largely unexplored.

Currently, there are few cohort studies of patients that have identified persistent cognitive impairment as a factor impacting remission after the acute phase. Given the scarcity of information concerning the post-acute phase, it is therefore essential to determine the long-term social and psychological outcomes and their daily effects on the social and functional life of this severe disease. This is especially important as the patients are young, with a median age of 21 years, and may face lasting limitations potentially detrimental to their success in professional, educational, or social environments.

详细描述

This study will help improve the management of patients with anti-NMDAR encephalitis : * By providing the first assessment of long-term cognitive, psychological and social consequences * By characterizing the patient's journey through the disease * By developing a standardized neuropsychological assessment which will improve the assessment of the patient in the post-acute phase As well as improving patient care in the long term through the drafting of specific medical recommendations.

注册库
clinicaltrials.gov
开始日期
2024年12月16日
结束日期
2025年4月4日
最后更新
4个月前
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Patients with NMDAR encephalitis
  • Age ≥ 18 years old
  • Patient affiliated to a social security system
  • No opposition from the patient

排除标准

  • Patients whithout NMDAR encephalitis
  • Age \< 18 years old
  • Patient under guardianship or curatorship
  • Patient with neurological disorders pre-existing encephalitis

结局指标

主要结局

Psychosocial questionnaires of patients with anti-NMDAR encephalitis after the acute phase of the disease.

时间窗: 50 MINUTES

Neuropsychological Questionnaires : * RAVLT questionnaire (no score) * EMPAN questionnaire (no score)

Analysis of cognitive assessments of patients with anti-NMDAR encephalitis after the acute phase of the disease.

时间窗: 40 MINUTES

Score of PROMs questionnaires : * FSS (score : /63) * HADS (score : /42) * EQ5D5L (score : /100) * BDI-II (no score ) * MMQ (no score) * PSQI (no score)

Patient's experience of the disease

时间窗: 1 Year

Score of Clinical questionnaire about patient's experience of the disease

研究点 (1)

Loading locations...

相似试验